Skip Navigation

This Article
Right arrow Abstract Freely available
Right arrow Print PDF (102K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (74)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Timofeev, E
Right arrow Articles by Florentiev, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Timofeev, E
Right arrow Articles by Florentiev, V.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1996 Oxford University Press 3142-3149

Footnote

Regioselective immobilization of short oligonucleotides to acrylic copolymer gels

Regioselective immobilization of short oligonucleotides to acrylic copolymer gels Edward N. Timofeev , Svetlana V. Kochetkova , Andrei D. Mirzabekov and Vladimir L. Florentiev*

Joint Human Genome Program: Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, 117984 Moscow , Russia and Argonne National Laboratory, Argonne , IL 60439, USA

Received May 28, 1996; Accepted July 3, 1996

ABSTRACT

Four types of polyacrylamide or polydimethylacrylamide gels for regioselective (by immobilization at the 3 ' end) of short oligonucleotides have been designed for use in manufacturing oligonucleotide microchips. Two of these supports contain amino or aldehyde groups in the gel, allowing coupling with oligonucleotides bearing aldehyde or amino groups, respectively, in the presence of a reducing agent. The aldehyde gel support showed a higher immobilization efficiency relative to the amino gel. Of all reducing agents tested, the best results were obtained with a pyridine-borane complex. The other supports are based on an acrylamide gel activated with glutaraldehyde or a hydroxyalkyl-functionalized gel treated with mesyl chloride. The use of dimethylacrylamide instead of acrylamide allows subsequent gel modifications in organic solvents. All the immobilization methods are easy and simple to perform, give high and reproducible yields, allow long durations of storage of the activated support, and provide high stability of attachment and low non-specific binding. Although these gel supports have been developed for preparing oligonucleotide microchips, they may be used for other purposes as well.

INTRODUCTION

Sequencing by hybridization (SBH) on oligonucleotide matrix or microchip containing a complete set of octanucleotides (or oligonucleotides of other reasonable length) is a new analytical method which was originally developed for fast sequencing of genomic DNA. Despite certain limitations, biological microchips show considerable promise as diagnostics for genetic diseases (for review see 1 ).

There are two alternative approaches to microchip preparation. In one approach, oligonucleotide probes are synthesized directly on a flat surface using either conventional chemical procedures ( 2 , 3 ) or photolithographic VLSIPS technology ( 4 ). Over the last few years we have developed another approach based on the immobilization of presynthesized, purified oligonucleotides in microcells of a functionalized polyacrylamide gel ( 5 , 6 ). The advantages of our approach are the higher capacity of the support and the possibility of immobilizing different amounts of oligonucleotides or oligonucleotides of different length in different cells; in particular, these features enable us to design a `normalized' microchip that yields equal hybridization signals for sequences of different G+C content by adjusting the concentrations of immobilized oligonucleotides ( 7 ).

Oligonucleotides are immobilized upon their 3'-dialdehyde termini by reaction with the gel hydrazide groups ( Scheme 1 ). Unfortunately, the hydrazide chemistry does not provide sufficient stability of attachment in repeated hybridization experiments. A variety of methods have been described for immobilization of biomolecules ( 8 , 9 ); and for attachment of oligonucleotides to polyacrylamide gels ( 10 ), some of them are well developed and corresponding gel supports are commercially available. However, functionalized gels for oligonucleotide microchips should meet some specific requirements, such as easy preparation and modification of the gel; high and reproducible immobilization yield; long storage life of the activated support; and high stability of attachment, and low nonspecific binding. Here we describe new functionalized acrylamide gels for oligonucleotide immobilization suitable for SBH applications.


Figure 1 . Kinetics of degradation of matrices obtained by condensation of a hydrazide matrix with oligonucleotide containing a dialdehyde group ( A ); an amine matrix with oligonucleotide containing dialdehyde group with reduction by pyridine-borane complex ( B ); and an aldehyde matrix with oligonucleotide containing an amino group with reduction by pyridine-borane complex ( C ). Stability of the matrixes was measured in 0.1 M triethylammonium acetate buffer, pH 7.0 at 60oC. For each immobilized oligonucleotide the decrease of radioactivity was monitored in three spots, 1 mm in diameter. For every spot, eight measurements (each for 3 s) were made using a digital radioactive monitor (Cole Parmer). Before measuring, glass-supported gels were rinsed with distilled water and dried. The experimental data are presented by mean points and error bars. The straight line is the fitting curve; the dashed line is the curve of the initial fast breakdown.

MATERIALS AND METHODS

All solvents were analytical or HPLC grade. General reagents were purchased from Fluka and Sigma Chemical Co. Glass slides for matrix preparation were from Corning Glass Works. 1 H NMR spectra were recordered on a Varian XL100, 100 MHz spectrometer; UV spectra were recorded on a Shimadzu UV-160A spectrophotometer.

Deoxyoligonucleotides were synthesized on an Applied Biosystems ABI 392-05 synthesizer using standard phosphoramidite chemistry. N -Me-uridine CPG ( 11 ) and amine CPG (Clontech) were used for the introduction of the methyluridine unit and the amino group into the 3' end of the oligonucleotides, respectively. Purification of oligonucleotides was performed by reverse phase HPLC (Gilson) using the following conditions: C 18 Nucleosil column, 7 [mu]m, 10-50%, CH 3 CN in 0.1 M triethylammonium acetate (TEAA), 30 min for oligonucleotides containing DMT protection groups, 0-25%, 30 min for unprotected oligonucleotides.

Radioactive labeling of oligonucleotides at their 5' ends with [[gamma]- 32 P]ATP was performed following standard protocol ( 12 ). The labeled oligonucleotides were isolated by electrophoresis on a denaturing polyacrylamide gel. 3'-methyluridine oligonucleotide was oxidized with 0.1 M NaIO 4 for 15 min at room temperature before immobilization to generate the 3'-dialdehyde unit.

Thin layer chromatography was carried out on Merck Kieselgel 60 TLC plates. Solvent systems for TLC: chloroform-methanol (9:1, system A); chloroform-methanol-hexane (9:1:10, system B); isopropyl alcohol-NH 4 OH-H 2 O (7:2:1, system C).

N -(3-triethoxysilyl)propylacrylamide

To a solution of acryloyl chloride (8.5 ml, 105 mmol) in dry dichloromethane (250 ml) cooled to 0oC, a mixture of 3-aminopropyltriethoxysilane (23.5 ml, 100 mmol) and triethylamine (13.9 ml, 100 mmol) in dichloromethane (50 ml) was added dropwise. After completion of the addition, the reaction mixture was stirred for 30 min and then filtered. The filtrate was evaporated to oil, diluted with hexane (100 ml) and filtered. The filtrate was concentrated to oil and distilled in vacuo . The product was obtained as a viscous oil (21.2 g, 77%), b.p. 142-145oC at 1 mm Hg. 1 H NMR (CDCl 3 ): 0.72 (t, 2H, SiCH 2 ), 1.27 (t, 9H, CH 3 ), 1.73 (m, 2H, CH 2 ), 3.39 (m, 2H, CH 2 NH), 3.88 (q, 6H, OCH 2 ), 5.67-6.35 (m, 3H, CH=CH 2 ), 6.35 p.p.m. (brs, 1H, NH).

N -(2-aminoethyl)acrylamide hydrochloride (Ia)

A solution of ethylenediamine (4.2 ml, 63 mmol) in dry ether (25 ml) was added slowly to a cooled (0oC) solution of acryloyl chloride (2.25 ml, 65 mmol) in dry ethyl ether (200 ml) under intensive stirring. After completion of the addition, (2-aminoethyl)acrylamide hydrochloride was filtered, washed with ether on the filter, and dried. The yield was 9.4 g (100%). 1 H NMR (DMSO-d 6 ): 3.02 (s, 2H, CH 2 NH 2 HCl), 3.12 (m, 2H, CH 2 NH), 5.29-6.28 (m, 3H, CH=CH2), 7.97 p.p.m. (brs, 1H, NH).

N -(6-aminohexyl)acrylamide hydrochloride (Ib)

Compound Ib was synthesized following the procedure described for Ia , with a 99% yield. 1 H NMR (DMSO-d 6 ): 1.36 (brs, 8H, 4CH 2 ), 2.78 (t, 2H, CH 2 NH 2 HCl), 3.10 (m, 2H, CH 2 NH), 5.48-6.40 (m, 3H, CH=CH 2 ), 8.10 p.p.m. (brs, 1H, NH).

N -(5,6-di- O -isopropylidene)hexylacrylamide (II)

1,2,6-Trihydroxyhexane (11.7 g, 87 mmol) was refluxed in the chloroform-acetone mixture (3:1 v/v, 300 ml) in the presence of catalytic amounts of p -toluenesulfonic acid for 6 h with azeotropic removal of water. The resulting solution was neutralized with 10 ml of triethylamine and washed with 10% aqueous sodium bicarbonate. The organic solution was dried over sodium sulfate and concentrated. The residual oil was distilled, yielding 11.9 g (79%) of 5,6-isopropylidenedioxahexane-1-ol ( IIa ). R f 0.45, solvent A. 1 H NMR (CDCl 3 ): 1.64 (s, 3H, CH 3 ), 1.69 (s, 3H, CH 3 ), 1.64-2.00 (m, 6H, 3CH 2 ), 2.34 (brs, 1H, OH), 3.56-4.28 p.p.m. (m, 5H, CH, CH 2 , CH 2 OH). Compound IIa (10 g, 57 mmol) in Py (100 ml) was reacted with CH 3 SO 2 Cl (6.6 g, 57 mmol, 4.5 ml) at room temperature for 12 h with stirring. The reaction was quenched with water (10 ml) and the reaction mixture was concentrated. The residue was diluted with chloroform, washed with water, dried over Na 2 SO 4 , and concentrated. The product, 5,6-isopropylidene-dioxahexane-1-mesylsulfonate ( IIb ) (11.92 g, 83%), was used without further purification. R f 0.7, solvent A. 1 H NMR (CDCl 3 ): 1.64 (s, 3H, CH 3 ), 1.69 (s, 3H, CH 3 ), 1.64-2.35 (m, 6H, 3CH 2 ), 3.18 (s, 3H, SO 2 CH 3 ), 3.56-4.28 (m, 3H, CH, CH 2 ), 4.34 p.p.m. (t, 2H, CH 2 OMs). Mesilate IIb (11.22 g, 44 mmol) was dissolved in dry DMF (10 ml), and LiN 3 (4.4 g, 88 mmol) was added. The reaction mixture was heated at 150oC for 30 min and then cooled and partitioned between water and ether (100/100 ml). The organic layer was dried and evaporated, yielding 5,6-isopropylidenedioxahexane-1-azide ( IIc ) (7.7 g, 88%), R f 0.7, solvent B. 1 H NMR (CDCl 3 ): 1.64 (s, 3H, CH 3 ), 1.69 (s, 3H, CH 3 ), 1.64-2.35 (m, 6H, 3CH 2 ), 3.18 (s, 3H, SO 2 CH 3 ), 3.47 (t, 2H, CH 2 N 3 ), 3.56-4.28 p.p.m. (m, 3H, CH, CH 2 ). To the solution of compound IIc (7.5 g, 37 mmol) in pyridine (100 ml), Ph 3 P (10.1 g, 37 mmol) was added under stirring. After 3 h, nitrogen liberation was completed. Aqueous ammonia (100 ml) was then added and the solution was kept at room temperature for 12 h. The reaction mixture was concentrated and diluted with water (100 ml). Ph 3 PO was filtered and the aqueous solution was evaporated. The residue was coevaporated several times with acetonitrile to remove water and distilled in vacuo . 5,6-Isopropylidene-dioxahexane-1-amine ( IId ) was obtained as colourless liquid (3.8 g, 60%), b.p. 110-113oC at 15 mm. Hg. R f 0.8, solvent C. 1 H NMR (CDCl 3 ): 1.64 (s, 3H, CH 3 ), 1.69 (s, 3H, CH 3 ), 1.60-2.25 (m, 6H, 3CH 2 ), 2.05 (s, 2H, NH 2 ), 2.92 (t, 2H, CH 2 N), 3.56-4.28 p.p.m. (m, 3H, CH, CH 2 ). A mixture of amine IId (1.03g, 5.9 mmol) and triethylamine (0.83 ml, 5.9 mmol) in dichloromethane (5 ml) was added dropwise to a vigorously stirred solution of acryloyl chloride (0.53 ml, 6.5 mmol) in dichloromethane (5 ml) at 0oC. After 30 min, hexan (15 ml) was added to the reaction mixture. Triethylamine hydrochloride was filtered off and the filtrate was evaporated. N -(5,6-di- O -isopropylidene)hexylacrylamide ( II ) was obtained as a viscous liquid (1.31 g, 97%), R f 0.5, solvent A. 1 H NMR (CDCl 3 ): 1.66 (s, 3H, CH 3 ), 1.71 (s, 3H, CH 3 ), 1.60-2.1 (m, 6H, 3CH 2 ), 3.40-4.32 (m, 5H, CH, CH 2 , CH 2 N), 5.62-6.42 p.p.m. (m, 3H, CH=CH 2 ).

General procedure for preparation of glass slides covered with gel

A chemically cleaned (washed in concentrated H 2 SO 4 , then with distilled water, and dried) glass slide was treated with Repel-Silane (Pharmacia) for 1-2 min and then washed with distilled water. After drying in a nitrogen stream, it was used as a hydrophobic cover glass. A second glass plate of the same surface quality was treated for 15-20 min with 5-10% solution of 3-(triethoxysilyl)propylacrylamide in 95% alcohol. After this, it was washed intensively with alcohol and dried in a nitrogen stream. This glass was used further as the gel binding glass. Two 20 [mu]m (or other size) teflon spacer strips were put on the sides of glass and then covered with the hydrophobic glass slide. The glass `sandwich' was fixed with two climbs. The monomer mixture was filtered before use. TEMED (0.1% v/v) was added to the monomer solution. The polymerizing mixture was then poured between the glass plates and was allowed to stand for 15-20 min. After completion of polymerization, the glass sandwich was rinsed with distilled water and carefully taken apart.

Amino matrix

A monomer mixture of the following content was used: 0.9 M N , N -dimethylacryamide, 0.1 M N -(2-aminoethyl)acrylamide hydrochloride, 0.02 M N , N -methylene-bis-acrylamide and 0.5-1 mg/ml ammonium persulfate. Before immobilization, amino matrices were washed in 0.1 M KOH for 5 min (to generate free amines), in distilled water for 30 min, and were then dried.

Aldehyde matrix

The monomer mixture contained 0.9 M N , N -dimethylacrylamide, 0.1 M N -(5,6-di- O -isopropylidene)hexylacrylamide, 0.02 M N , N -methylene-bis-acrylamide and 0.5-1 mg/ml ammonium persulfate. Aldehydes were generated by treatment with 80% acetic acid at 60oC for 1 h and then with 0.1 M NaIO 4 at room temperature for 30 min. The aldehyde matrix was then washed at 30oC for 1 h in distilled water and dried.

Standard hydrazide matrix

The monomer mixture contained 1 M acryamide, 0.02 M N , N -methylene-bis-acrylamide and 0.5-1 mg/ml ammonium persulfate. Gel chips were treated with hydrazine hydrate at room temperature for 12 h, then washed with 5% acetic acid for 1 h and with distilled water for 1 h, and dried.

Hydrazide matrix from 2-hydroxyethyl copolymer

The monomer mixture contained 0.9 M N , N -dimethylacryamide, 0.1 M 2-hydroxyethylacrylate, 0.02 M N , N -methylene-bis-acrylamide and 0.5-1 mg/ml ammonium persulfate. The polymerized gel matrix was treated with hydrazine hydrate at room temperature for 12 h, then washed with 5% acetic acid for 1 h and with distilled water for 1 h, and dried.

Methanesulfonate-activated matrix

The monomer mixture contained 0.9 M N , N -dimethylacryamide, 0.1 M 2-hydroxyethylacrylate, 0.02 M N , N -methylene-bis-acrylamide and 0.5-1 mg/ml ammonium persulfate. Polymerized gel matrix was treated with 50% 3-aminopropanol in EtOH at 50oC for 6 h. After a 1 h wash in distilled water at 30oC, the matrix was dried and treated with 1 M CH 3 SO 2 Cl in dry pyridine for 8 h at room temperature. Then matrix was washed for 5 min with ethanol, for 1 h with distilled water, and dried.

Glutaraldehyde-activated matrix

The monomer mixture contained 1 M acryamide, 0.02 M N , N -methylene-bis-acrylamide and 0.5-1 mg/ml ammonium persulfate. Gel chips were treated with a mixture of glutaraldehyde (25% aqeous solution) and phosphate buffer pH 7.5 (1:1) at 40oC for 12 h, were washed with distilled water for 1 h, and then were dried.

Oligonucleotide immobilization

The following conditions were used for immobilization. Hydrazide matrices: 1 [mu]l of oxidized oligonucleotide in water, overnight; amino matrix (or aldehyde matrix): 1 [mu]l of oxidized oligonucleotide (or amino-oligonucleotide for aldehyde support) in water plus 1 [mu]l of reducing agent (0.1 M solution in water for NaCNBH 3 and Me 3 NBH 3 , 0.1 M solution in 10% aqueous methanol for PyBH 3 ), 1.5 h; methanesulfonate-activated matrix: 1 [mu]l of amino-oligonucleotide in 0.1 M K 2 CO 3 , overnight; glutaraldehyde activated matrix: 1 [mu]l of amino-oligonucleotide in water, overnight. Immobilization was carried out at room temperature in a chamber at 100% humidity. Unmodified oligonucleotides in the same solutions as the immobilized oligonucleotides were used as a control. Each spot (~1 mm in diameter) containing immobilized or control oligonucleotide had 15 000-25 000 c.p.m. of activity and contained 200-500 pmol of oligonucleotide. After immobilization, each matrix was washed for 20 min with 0.1 M TEAA at 50oC.

RESULTS AND DICUSSION

Attachment of gel support to glass surface

Unlike some other applications in which gel beads can be used without any additional support, gel-based SBH on microchips requires solid support for the gel cells. Conventionally in gel microchip preparation, acrylamide or another acrylic monomer polymerizes in the form of a thin film on a flat glass surface derivatized with acrylic groups. The polymer film attached to glass is then used for chemical treatment (hydrazinolysis or other), cell preparation and immobilization. Insufficient resistance of the linkage between gel and glass towards modifying reagents may result in exfoliation of cells. The commonly used methacryloxypropyltriethoxysilane (Bind-Silane) modification of the surface gives an attachment of the gel that is unstable to hydrazine treatment. We found that 3-(triethoxysilylpropyl)acrylamide provides a much better resistance to drastic conditions of gel treatment. This compound was synthesized starting from 3-aminopropyltriethoxysilane and acryloyl chloride. Several hours of exposure to hydrazine hydrate at room temperature or to 50% 3-aminopropanol in ethyl alcohol at 50oC did not cause any damage or exfoliation of a 20 [mu]m polydimethylacrylamide film.

Functionalization of gel

The common methods for polyacrylamide (and polymorpholino- acrylamide) gel functionalization are based on treatment of the polymerized support with reagents such as hydrazine or ethylenediamine ( 13 - 15 ). In routine microchip production, we also use hydrazinolysis of polymerized acrylamide films (Scheme 1 ). In this work, we introduced the functional groups by copolymerization reactions and by subsequent modification of the active groups in the copolymer. Some examples of functionalized polyacrylamide copolymers for coupling of glycoprotein and enzymes have been described in which N -hydroxysuccinimide acrylic derivatives were used ( 11 , 16 ). Commercially available oxirane acrylic support (Sigma) is another example of a derivatized copolymer. The copolymerization approach offers easy, controlled modification of acrylic polymers. The use of substituted acrylamides (dimethylacrylamide or morpholinoacrylamide) provides an additional possibility for subsequent modification both in aqueous and organic media. Thus, a variety of functional groups can be generated in the gel, or the linker length can be increased by the usual synthetic methods.


Scheme 1


We suggest two types of gel support, containing amines or aldehydes, for stable immobilization of oligonucleotides. These gels allow attachment of oxidized 3'-ribo- or aminoalkyloligonucleotides, respectively, in the presence of a reducing agent such as sodium cyanoborohydride. Amino groups were introduced into polyacrylamide and polydimethylacrylamide gels by copolymerization of the corresponding acrylic monomer with [omega]-aminoalkylacryamide hydrochlorides ( I ).{{fwd 29 {{roman {{C H} sub 2}} {back 18 roman =}}} {{{roman {C H - C O N H - ( C H}}} sub 2} {) sub n} - {roman {{N H} sub 2}} {back 31 roman cdot} {back 25 {{roman {H C 1}}}}} from size 8 roman {{size 10 bold roman I} from size 10 {{{size 10 bold a} {size 10 :} {size 10 italic n} {size 10 =} 2} from {{size 10 bold b} {size 10 :} {size 10 italic n} {size 10 {= 6}}}}}

Compounds Ia and Ib may be easily prepared by acylation of aliphatic diamines with acryloyl chloride under mild conditions in nearly quantitative yield. The synthesized compounds did not contain disubstituted products (as evident from their NMR spectra). Since C-6 derivative Ib has a limited solubility in water (0.06 g/ml), we used monomer Ia for preparing amino matrices.

The presence of an amino group substantially decreases the monomer activity in copolymerization. The number of NH 2 groups incorporated into the polyacrylamide gel [1 M gel, 9:1 acrylamide to N -(2-aminoethyl)acrylamide molar ratio] was estimated by staining a 100 [mu]m-thick gel film on a glass slide with 2,6-dinitrofluorobenzene and analyzing photometrically at 365 nm (glass slides are transparent at this wavelength). According to the photometry, 10% of the amino derivative was incorporated into the copolymer. This amount corresponds to the level of hydrazine modification by a standard procedure (~1% of the amide groups are modified) and is quite sufficient for immobilization of 0.1-10 pmol of oligonucleotide in 100 * 100 * 20 [mu]m cells. In several immobilization experiments, dimethylacrylamide was used instead of acrylamide. Polydimethylacrylamide amino matrices were 20 [mu]m thick and had a 0.01 M concentration of amino groups. No additional modifications were carried out with amino matrices except for a short washing with 0.1 M KOH to generate free amines.

Another monomer, (5,6- O -isopropylidene-5,6-dihydroxyhexyl)acrylamide ( II ), was used for preparing an aldehyde-derivatized gel support ( Scheme 2 ). The synthetic route for II is shown in Scheme 2 . The solubility of protected monomer II in water is limited but sufficient for preparing a 0.1 M solution. More concentrated solutions for increased functionalization can be easily prepared after removal of the isopropylidene-protecting group by aqueous triflouroacetic acid. Dimethylacrylamide was copolymerized with II at the 9:1 molar ratio (crosslinking by N , N -methylene-bis-acrylamide) to give an isopropylidene-protected diol function. The gel films were then treated with aqueous acetic acid and 0.1 M NaIO 4 , producing an aldehyde matrix.


Scheme 2


Other types of activation start from dimethylacrylamide- [beta]-hydroxyethylacrylate copolymers. 2-Hydroxyethyl acrylate is a commercially available, water-soluble monomer that allows one to introduce into the gel desired amounts of hydroxyethyl esters. Due to anhimeric assistance of beta oxygen ( 17 ), the hydroxyethyl group may be easily and selectively substituted by nucleophilic agents like hydrazine, diamines, aminoalcohols, etc. Modification of hydroxyethylacrylamide-dimethylacrylamide copolymer provides the possibility of obtaining mesyl ( Scheme 3 ) and high capacity hydrazide-activated matrices ( Scheme 1 ). For these copolymers we used 0.1 M 2-hydroxyethylacrylate and 0.9 M dimethylacrylamide. Additionally we prepared glutaraldehyde-activated (Scheme 4 ) and standard hydrazide acrylamide supports for control immobilization.


Scheme 3


Scheme 4


We did not use unstable active groups like NHS, which do not allow long-term storage of the activated support and may result in remarkable, uncontrolled differences in the concentrations of immobilized oligonucleotides on the microchip.

Immobilization of oligonucleotides

Immobilization was carried out with 5'- 32 P-labeled oligonucleotides: ATGCTACT-X, where X is an oxidized ribose unit from the methyluridine fragment or an NH 2 group (oligoR or oligoA, respectively). An amino group was attached to the 3' end of the oligonucleotide through a C 6 linker. The unmodified octanucleotide (oligoP) was used as a control. The chemistry of immobilization with simultaneous reduction is shown in Schemes 2 and 5 . The efficiency of binding was estimated by measuring radioactivity before and after washing for 20 min in 0.1 M TEAA buffer at 50oC. As expected, both the amino and aldehyde matrices provided fast attachment in high yield (Table 1 ). The slightly lower efficiency of the amino matrix is probably caused by partial elimination [E1cB mechanism ( 18 )] of the 3'-dialdehyde moiety as pH rises in the course of reduction. The highly efficient aldehyde support exhibited, however, an increased non-specific binding of the control octamer. We used sodium cyanoborohydride, pyridine-borane and trimethylamine-borane complexes as reducing agents. The best results were obtained with pyridine-borane complex for both the amino and the aldehyde supports (yields were 74 and 97%, respectively). A probable explanation for this fact could be the higher reactivity of the pyridine-borane complex under the conditions used.


Scheme 5


Table 1 Efficiency of immobilization Immobilization of oxidized oligoR on hydrazide supports prepared by hydrazinolysis of either polyacrylamide gel or 2- hydroxyethylacrylate/polydimethylacrylamide copolymer showed high efficiency and low nonspecific binding (Table 1 ). These data are consistent with our previous results on hydrazide matrices ( 12 ).

Activation by glutaraldehyde provided reactive, but low selectivity immobilization of oligoA. A high level of nonspecific binding is closely related to the mechanism of activation, which involves the reaction of the relatively inert amide groups of the support with bifunctional glutaraldehyde trimer (Scheme 4 4) ( 19 ). Evidently, the amino groups of nucleotide bases exhibit some reactivity toward activated sites, although lower than that of the primary aliphatic amino group of oligoA. This type of activation gives good results in immobilization of proteins ( 9 ) and may be successfully applied to the preparation of protein microchips. In contrast, methylsulfonate functionalization results in low-yield attachment of amino-oligonucleotide (oligoA) with practically no nonspecific binding of control oligomer P.

Stability of attachment of the oligonucleotides

The stability of oligonucleotide matrices was monitored by measuring the decrease in remaining radioactivity during 9 h of washing in 0.1 M TEAA buffer at 60oC and pH 7.0. Regardless of the type of attachment, all the matrices showed a rapid loss of the bound material (~20%) in the first 2 h. Further decay was 10-100 times slower. The relatively fast initial breakdown of the matrix seems to be caused by the elimination of short, oligonucleotide-containing polyacrylamide (or polydimethylacrylamide) chains that are not linked to the entire polymer lattice.

For estimating the relative stability for different matrices, we fitted experimental points by the two-exponential decay function: {{B = A} sub 1} cdot e x p ( - {{italic k} sub 1} {{{italic t} ) + A} sub 2} cdot e x p ( - {{italic k} sub 2} {italic t} {roman )}

where B is amount of bound labeled and A 1 , A 2 , k 1 and k 2 are constants. The first term of the equation represents the fast initial decrease of radioactivity (rate constant k 1 ). The rate constant of the slow stage ( k 2 ) reflects the overall sum of reactions resulting in loss of label: cleavage of the oligonucleotide-to-gel bonds, hydrolysis of internucleotide and terminal phosphates, destruction of polyacrylamide gel, etc. Only the first of all these processes depends on the type of attachment. The experimental data and fitting curves are presented in Figure 1 ; the calculated parameters A 1 , A 2 , k 1 and k 2 are given in Table 2 .


Table 2 Kinetics of matrix degradation *Half-time of slow process. Standard hydrazide matrix. (2-Hydroxyethyl)acrylate copolymer derived by hydrazine.


The fast initial decrease depends only slightly on the gel preparation mode, while the rates of the second slow stage differ by a factor of >10. The results obtained are clearly divisible into two main groups. The first group includes oligonucleotides attached to the gel through relatively easily hydrolyzable bonds such as hydrazone or imine. In these cases, the half-life of matrix degradation is ~40 h (Table 2 ). The same half-life for matrices treated by trimethylamine-borane complex indicates that this agent does not reduce imino groups under the conditions used. The matrices in which oligonucleotides are coupled to the gel by a very stable aminoalkyl bond (half-life of destruction is ~450 h) form the second group. The glutaraldehyde-activated supports, as well as the amine and aldehyde matrices reduced by pyridine-borane complex, fall into this category. In this case, the imino groups are reduced completely. In contrast with the pyridine-borane complex, sodium cyanborohydride reduces imines only partly, as judged from the half-life of matrix degradation (100-130 h).

It is important to note here that none of the three borane complexes reduce N -(acylamino)dihydroxymorpholine cycle (hydrazide matrix, Scheme 1 ), as evidenced by the absence of changes in hydrazide matrix stability after treatment with reductants.

Thus, from all tested methods, high-yield immobilization of amino-oligonucleotides on aldehyde gel supports providing stable attachment may be considered as the most effective procedure for oligonucleotide gel microchip preparation. In addition, it does not require additional steps for activation of oligonucleotides (oxidation of 3'-ribo unit) and makes possible immobilization on the 3' or 5' end.

ACKNOWLEDGEMENTS

We thank Dr A. Mozoleva, EIMB, for recording NMR spectra, and D. Prudnikov, EIMB, for labeling of oligonucleotides. This work was supported by Grants 558 and 562 of the Russian Human Genome Program, by Grant DE-FG02-93ER61538 of the US Department of Energy, and by a collaboration agreement with Affymetrix. We thank L. Novikova and D. E. Nadziejka for editorial assistance.

REFERENCES

1 Mirzabekov, A. (1994) Trends Biol. Tech. 12, 21-32.

2 Maskos, U. and Southern, E. (1992) Nucleic Acids Res. 20, 1679-1784. MEDLINE Abstract

3 Lamture, J.B., Beattie, K.L., Burke, B.E., Eggers, M.D., Ehrlich, D.J., Fowle, R., Hollis, M.A., Kosicki, B.B., Reich, R.K, Smith, S.R., Varma, R.S. and Hogan, M.E. (1994) Nucleic Acids Res. 22, 2121-2125. MEDLINE Abstract

4 Pease, A.C., Solas, D., Sullivan, E.J., Cronin, M.T., Holmes, C.P. and Fodor, S.P.A. (1994) Proc. Natl. Acad. Sci. USA 91, 5022-5026. MEDLINE Abstract

5 Khrapko, K.A., Lysov, Yu., Khorlin, A., Shick, V., Florentiev, V. and Mirzabekov, A. (1989) FEBS Lett. 258, 118-122.

6 Yershov, G., Barsky, V., Belgovsky, A., Kirillov, E., Kreindlin, E., Ivanov, I., Parinov, S., Guschin, D., Drobishev, A., Dubiley, S. and Mirzabekov, A. (1996) Proc. Natl. Acad. Sci. USA in press.

7 Livshits, M., Florentiev, V. and Mirzabekov, A. (1994) J. Biomol. Struct. Dyn. 11, 783-795. MEDLINE Abstract

8 Narayanan, S.R. and Crane, L.J. (1990) Trends Biol. Tech. 8, 12-16.

9 Scouten, W.H., Luong, J.H.T. and Brown, R.S. (1995) Trends Biol. Tech. 13, 178-185.

10 Fahy, E., Davis, G.R., DiMichele, L.J. and Ghosh, S.S. (1993) Nucleic Acids Res. 21, 1819-1826. MEDLINE Abstract

11 Pless, D.D., Lee, Y.C., Roseman, S. and Schnaar, R.L. (1983) J. Biol. Chem. 258, 2340-2349. MEDLINE Abstract

12 Ivanov, I., Khrapko, K., Chernyi, A., Khorlin, A., Lysov, Yu., Florentiev, V. and Mirzabekov, A. (1991) Nucleic Acids Res. Symp. Ser. N 24, 189-190.

13 Inman, J.K. and Dintzis, H.M. (1969) Biochemistry 8, 4074-4082. MEDLINE Abstract

14 Narang, C.K., Brunfeldt, K.and Norris, K. (1977) Tetrahedron Lett. 18, 1819-1822.

15 Otsuka, E., Takashima, H. and Ikehara, M. (1981) Tetrahedron Lett. 22, 765-768.

16 Pollak, A., Blumenfeld, H., Wax, M., Baughn, R.L. and Whitesides, G.M. (1980) J. Am. Chem. Soc. 102, 6324-6333.

17 Pezst, F.J. (1971) Oxonium Ions in Organic Chemistry. Verlag Chemie, Weinheim/Bergstasse, pp. 100-127.

18 Saunders, S.W.H. and Cockerill, C.A.F. (1973) Mechanism of Elimination Reactions. John Wiley and Sons, NY.

19 Cabrera, K.E. and Wilcheck, M. (1988) Trends Anal. Chem. 7, 58-63.

20 Sambrook, J., Fritsch, E.F. and Maniatis, T. (1989) Molecular cloning: A Laboratory Manual, 2nd Ed. Cold Spring Harbor Laboratory Press, Plainview, NY.


Return

* To whom correspondence should be addressed at Engelhardt Institute of Molecular Biology, Vavilova 32, Moscow 117984, Russian Federation
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Clin. Chem.Home page
S. Battistella, F. Damin, M. Chiari, K. Delgrosso, S. Surrey, P. Fortina, M. Ferrari, and L. Cremonesi
Genotyping {beta}-Globin Gene Mutations on Copolymer-Coated Glass Slides with the Ligation Detection Reaction
Clin. Chem., October 1, 2008; 54(10): 1657 - 1663.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
S. Pfander, R. Fiammengo, S. I. Kirin, N. Metzler-Nolte, and A. Jaschke
Reversible site-specific tagging of enzymatically synthesized RNAs using aldehyde-hydrazine chemistry and protease-cleavable linkers
Nucleic Acids Res., February 28, 2007; 35(4): e25 - e25.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
A. Pemov, H. Modi, D. P. Chandler, and S. Bavykin
DNA analysis with multiplex microarray-enhanced PCR
Nucleic Acids Res., January 20, 2005; 33(2): e11 - e11.
[Abstract] [Full Text] [PDF]


Home page
Appl. Environ. Microbiol.Home page
H. Urakawa, S. El Fantroussi, H. Smidt, J. C. Smoot, E. H. Tribou, J. J. Kelly, P. A. Noble, and D. A. Stahl
Optimization of Single-Base-Pair Mismatch Discrimination in Oligonucleotide Microarrays
Appl. Envir. Microbiol., May 1, 2003; 69(5): 2848 - 2856.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
S. Raddatz, J. Mueller-Ibeler, J. Kluge, L. Wass, G. Burdinski, J. R. Havens, T. J. Onofrey, D. Wang, and M. Schweitzer
Hydrazide oligonucleotides: new chemical modification for chip array attachment and conjugation
Nucleic Acids Res., November 1, 2002; 30(21): 4793 - 4802.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
S. Lapa, M. Mikheev, S. Shchelkunov, V. Mikhailovich, A. Sobolev, V. Blinov, I. Babkin, A. Guskov, E. Sokunova, A. Zasedatelev, et al.
Species-Level Identification of Orthopoxviruses with an Oligonucleotide Microchip
J. Clin. Microbiol., March 1, 2002; 40(3): 753 - 757.
[Abstract] [Full Text] [PDF]


Home page
Appl. Environ. Microbiol.Home page
H. Urakawa, P. A. Noble, S. El Fantroussi, J. J. Kelly, and D. A. Stahl
Single-Base-Pair Discrimination of Terminal Mismatches by Using Oligonucleotide Microarrays and Neural Network Analyses
Appl. Envir. Microbiol., January 1, 2002; 68(1): 235 - 244.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
E. Timofeev and A. Mirzabekov
Binding specificity and stability of duplexes formed by modified oligonucleotides with a 4096-hexanucleotide microarray
Nucleic Acids Res., June 15, 2001; 29(12): 2626 - 2634.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
A. S. Krylov, O. A. Zasedateleva, D. V. Prokopenko, J. Rouviere-Yaniv, and A. D. Mirzabekov
Massive parallel analysis of the binding specificity of histone-like protein HU to single- and double-stranded DNA with generic oligodeoxyribonucleotide microchips
Nucleic Acids Res., June 15, 2001; 29(12): 2654 - 2660.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
V. A. Vasiliskov, D. V. Prokopenko, and A. D. Mirzabekov
Parallel multiplex thermodynamic analysis of coaxial base stacking in DNA duplexes by oligodeoxyribonucleotide microchips
Nucleic Acids Res., June 1, 2001; 29(11): 2303 - 2313.
[Abstract] [Full Text] [PDF]


Home page
Appl. Environ. Microbiol.Home page
S. G. Bavykin, J. P. Akowski, V. M. Zakhariev, V. E. Barsky, A. N. Perov, and A. D. Mirzabekov
Portable System for Microbial Sample Preparation and Oligonucleotide Microarray Analysis
Appl. Envir. Microbiol., February 1, 2001; 67(2): 922 - 928.
[Abstract] [Full Text]


Home page
Nucleic Acids ResHome page
S. A. Surzhikov, E. N. Timofeev, B. K. Chernov, J. B. Golova, and A. D. Mirzabekov
Advanced method for oligonucleotide deprotection
Nucleic Acids Res., April 15, 2000; 28(8): e29 - e.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
J. D. Andreadis and L. A. Chrisey
Use of immobilized PCR primers to generate covalently immobilized DNAs for in vitro transcription/translation reactions
Nucleic Acids Res., January 15, 2000; 28(2): e5 - e5.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
S. D. Jayasena
Aptamers: An Emerging Class of Molecules That Rival Antibodies in Diagnostics
Clin. Chem., September 1, 1999; 45(9): 1628 - 1650.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Print PDF (102K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (74)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Timofeev, E
Right arrow Articles by Florentiev, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Timofeev, E
Right arrow Articles by Florentiev, V.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?